Logotipo del repositorio
Logotipo del repositorio
 

Tormenta tiroidea: abordaje diagnóstico y terapéutico

Vista sencilla de ítem
datacite.rightshttp://purl.org/coar/access_right/c_abf2
dc.contributor.authorCorrea Guerrero, José
dc.contributor.authorCorrales Santander, Hugo
dc.contributor.authorYepes Caro, Jorge
dc.contributor.authorBello Simanca, Jesús
dc.contributor.authorRodríguez Arrieta, Luis
dc.contributor.authorCastellanos Pinedo, Alejandro
dc.contributor.authorRodríguez Garizabalo, Elguis
dc.contributor.authorDueñas Castell, Carmelo
dc.date.accessioned2026-02-02T15:23:20Z
dc.date.available2026-02-02T15:23:20Z
dc.date.issued2025
dc.description.abstractLa tormenta tiroidea (TT) es una patología infrecuente, pero potencialmente mortal si no se detecta y trata oportunamente. Se caracteriza por manifestaciones clínicas graves a nivel del sistema nervioso central, cardiovascular y gastrointestinal, asociado a niveles elevados de triyodotironina (T3) libre y tiroxina (T4) libre. Las infecciones y/o el abandono del tratamiento son los desencadenantes más frecuentes. Identificar el factor desencadenante, reducir los niveles circulantes de hormonas tiroideas, y admitir a unidad de cuidado intensivo se convierten en la piedra angular del tratamiento. En la presente revisión, basados en un escenario clínico, proporcionaremos información con respecto al abordaje diagnóstico y terapéutico de una TT. © 2024 Asociacion Colombiana de Medicina CrÍtica y Cuidado lntensivo. Publicado por Elsevier España, S.L.U. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares.spa
dc.description.abstractThyroid storm (TT) is a rare but potentially fatal condition if not detected and treated promptly. It is characterized by severe clinical manifestations at the level of the central nervous system, cardiovascular system, and gastrointestinal system, associated with elevated levels of free triiodothyronine (T3) and free thyroxine (T4). Infections and/or treatment discontinuationeng
dc.identifier.citationJ. Correa-Guerrero, H. Corrales Santander, J. Yepes Caro et al., Tormenta tiroidea: abordaje diagnóstico y terapéutico, Acta Colombiana de Cuidado Intensivo, https://doi.org/10.1016/j.acci.2024.10.010
dc.identifier.doihttps://doi.org/10.1016/j.acci.2024.10.010
dc.identifier.issn0122-7262 (Electrónico)
dc.identifier.urihttps://hdl.handle.net/20.500.12442/17318
dc.identifier.urlhttps://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0122726224001083?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0122726224001083%3Fshowall%3Dtrue&referrer=
dc.language.isospa
dc.publisherAsociación Colombiana de Medicina Crítica y Cuidado lntensivospa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationaleng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceActa Colombiana de Cuidado Intensivospa
dc.sourceVol. 25 No. 1 Año 2025spa
dc.subjectTormenta tiroideaspa
dc.subjectTirotoxicosisspa
dc.subjectHipertiroidismospa
dc.subjectEmergencia endocrinaspa
dc.subjectTerapia antitiroideaspa
dc.subject.keywordsThyroid stormeng
dc.subject.keywordsThyrotoxicosiseng
dc.subject.keywordsHyperthyroidismeng
dc.subject.keywordsEndocrine emergencyeng
dc.titleTormenta tiroidea: abordaje diagnóstico y terapéuticospa
dc.type.driverinfo:eu-repo/semantics/article
dc.type.spaArtículo científico
dcterms.referencesChiha M, Samarasinghe S, Kabaker AS. Thyroid Storm: An Updated Review. J Intensive Care Med. 2015;30:131---40, http://dx.doi.org/10.1177/0885066613498053.eng
dcterms.referencesDe Almeida R, McCalmon S, Cabandugama PK. Clinical Review and Update on the Management of Thyroid Storm. Mo Med. 2022;119:366---71.eng
dcterms.referencesGalindo RJ, Hurtado CR, Pasquel FJ, García Tome R, Peng L, Umpierrez GE. National Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and Without Thyroid Storm in the United States, 2004- 2013. Thyroid. 2019;29:36---43, http://dx.doi.org/10.1089/ thy.2018.0275.eng
dcterms.referencesAkamizu T, Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, et al. Diagnostic Criteria, Clinical Features, and Incidence of Thyroid Storm Based on Nationwide Surveys. Thyroid. 2012;22:661---79, http://dx.doi.org/10.1089/thy.2011.0334.eng
dcterms.referencesOno Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Factors Associated With Mortality of Thyroid Storm: Analysis Using a National Inpatient Database in Japan. Medicine. 2016;95:e2848, http://dx.doi.org/10.1097/MD.0000000000002848.eng
dcterms.referencesYlli D, Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Pol Arch Intern Med. 2019, http://dx.doi.org/ 10.20452/pamw.14876.eng
dcterms.referencesAkamizu T. Thyroid Storm: A Japanese Perspective. Thyroid. 2018;28:32---40, http://dx.doi.org/10.1089/thy.2017.0243.eng
dcterms.referencesFliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabet Endocrinol. 2015;3:816---25, http://dx.doi.org/10.1016/S2213-8587(15)00225-9.eng
dcterms.referencesBrooks MH. Free Thyroxine Concentrations in Thyroid Storm. Ann Intern Med. 1980;93:694, http://dx.doi.org/ 10.7326/0003-4819-93-5-694.eng
dcterms.referencesSilva JE, Bianco SDC. Thyroid---Adrenergic Interactions: Physiological and Clinical Implications. Thyroid. 2008;18:157---65, http://dx.doi.org/10.1089/thy.2007.0252.eng
dcterms.referencesWartofsky L, Klubo-Gwiezdzinska J. Thyroid Storm (Thyrotoxic Crisis). En: Luster M, Duntas LH, Wartofsky L, editores. The Thyroid and Its Diseases. Springer International Publishing; 2019. p. 357---66, http://dx.doi.org/10.1007/978-3-319-72102-6 25.eng
dcterms.referencesBinod P, Wajeeha A, Kamal B. Thyroid Storm. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan [consultado 5 Oct 2024]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK448095/.eng
dcterms.referencesSwee DS, Chng CL, Lim A. Clinical Characteristics and Outcome of Thyroid Storm: A Case Series and Review of Neuropsychiatric Derangements in Thyrotoxicosis. Endocr Pract. 2015;21:182---9, http://dx.doi.org/10.4158/EP14023.OR.eng
dcterms.referencesPumphrey T, Rizzo A. Thyroid Storm Unmasked: A Rare Case of Acute COVID-19-Induced Thyroid Storm. Cureus. 2023, http://dx.doi.org/10.7759/cureus.45906.eng
dcterms.referencesEatz TA, Rios P, Penaherrera Oviedo CA, Lagari V. Thyroid storm triggered by thyroid nodule fine needle aspiration biopsy: a case report. AME Case Rep. 2024;8, http://dx.doi.org/10.21037/ acr-23-63, 15-15.eng
dcterms.referencesLath D, Nandipati VS, Jebasingh F, Cherian KE, Kapoor N, Asha HS, et al. A Lower Prevalence of Central Nervous System and Higher Prevalence of Cardiac Symptoms Characterises Indian Patients with Thyrotoxic Storm: A Retrospective Analysis. Indian Journal of Endocrinology and Metabolism. 2024;28:302---7, http://dx.doi.org/10.4103/ijem.ijem 355 23.eng
dcterms.referencesElendu C, Amaechi DC, Amaechi EC, Chima-Ogbuiyi NL, Afuh RN, Arrey Agbor DB, et al. Diagnostic criteria and scoring systems for thyroid storm: An evaluation of their utility --- comparative review. Medicine. 2024;103:e37396, http://dx.doi.org/ 10.1097/MD.0000000000037396.eng
dcterms.referencesVadini V, Vasistha P, Shalit A, Maraka S. Thyroid storm in pregnancy: a review. Thyroid Res. 2024;17:2, http://dx.doi.org/ 10.1186/s13044-024-00190-y.eng
dcterms.referencesRoss DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26:1343---421, http://dx.doi.org/10.1089/thy.2016.0229.eng
dcterms.referencesSatoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition): The Japan Thyroid Association and Japan Endocrine Society Taskforce Committee for the establishment of diagnostic criteria and nationwide surveys for thyroid storm [Opinion]. Endocr J. 2016;63:1025---64, http://dx.doi.org/10.1507/endocrj.EJ16-0336.eng
dcterms.referencesKahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J. 2018;7:167---86, http://dx.doi.org/10.1159/000490384.eng
dcterms.referencesBourcier S, Coutrot M, Kimmoun A, Sonneville R, De Montmollin E, Persichini R, et al. Thyroid Storm in the ICU: A Retrospective Multicenter Study. Crit Care Med. 2020;48:83---90, http://dx.doi.org/10.1097/CCM.0000000000004078.eng
dcterms.referencesFarooqi S, Raj S, Koyfman A, Long B. High risk and low prevalence diseases: Thyroid storm. Am J Emerg Med. 2023;69:127---35, http://dx.doi.org/10.1016/j.ajem. 2023.03.035.eng
dcterms.referencesNayak B, Burman K. Thyrotoxicosis and Thyroid Storm. Endocrinol Metab Clin North Am. 2006;35:663---86, http://dx.doi.org/10.1016/j.ecl.2006.09.008.eng
dcterms.referencesWang R, Nelson JC, Wilcox RB. Salsalate and Salicylate Binding to and their Displacement of Thyroxine from Thyroxine-Binding Globulin, Transthyretin, and Albumin. Thyroid. 1999;9:359---64, http://dx.doi.org/10.1089/thy.1999.9.359.eng
dcterms.referencesInman BL, Long B. Thyrotoxicosis. Emerg Med Clin North Am. 2023;41:759---74, http://dx.doi.org/10.1016/ j.emc.2023.06.005.eng
dcterms.referencesIdrose AM. Acute and emergency care for thyrotoxicosis and thyroid storm. Acute Med Surg. 2015;2:147---57, http://dx.doi.org/10.1002/ams2.104.eng
dcterms.referencesVillacís-Uyaguari C, Torres D. Tormenta tiroidea, una emergencia endocrina. Directrices actualizadas de su manejo. INSPILIP. 2023;7, http://dx.doi.org/10.31790/inspilip.v7i22.423.spa
dcterms.referencesJacobi J. Management of Endocrine Emergencies in the ICU. J Pharm Pract. 2019;32:314---26, http://dx.doi.org/ 10.1177/0897190019834771.eng
dcterms.referencesAbuid J, Larsen PR. Triiodothyronine and Thyroxine in Hyperthyroidism. Comparison of the Acute Changes During Therapy With Antithyroid Agents. J Clin Invest. 1974;54:201---8, http://dx.doi.org/10.1172/JCI107744.eng
dcterms.referencesFurukawa Y, Tanaka K, Isozaki O, Suzuki A, Iburi T, Tsuboi K, et al. Prospective Multicenter Registry---Based Study on Thyroid Storm: The Guidelines for Management From Japan Are Useful. J Clin Endocrinol Metab. 2024:dgae124, http://dx.doi.org/10.1210/clinem/dgae124.eng
dcterms.referencesIsozaki O, Satoh T, Wakino S, Suzuki A, Iburi T, Tsuboi K, et al. Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid storm. Clin Endocrinol. 2016;84:912---8, http://dx.doi.org/10.1111/cen.12949.eng
dcterms.referencesNakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N, et al. Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves’ Disease. J Clin Endocrinol Metab. 2007;92:2157---62, http://dx.doi.org/10.1210/jc.2006-2135.eng
dcterms.referencesNabil N, Miner DJ, Amatrudaf JM. Methimazole: An Alternative Route of Administration*. J Clin Endocrinol Metab. 1982;54:180---1, http://dx.doi.org/10.1210/jcem-54-1-180.eng
dcterms.referencesAbdi H, Amouzegar A, Azizi F. Antithyroid Drugs. Iran J Pharma Res. 2019;18 Supl. 1:e124684, http://dx.doi.org/ 10.22037/ijpr.2020.112892.14005.eng
dcterms.referencesSato S, Noh JY, Sato S, Suzuki M, Yasuda S, Matsumoto M, et al. Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38mg/Day and Methimazole 30mg/Day as Initial Therapy for Graves’ Disease Patients with Moderate to Severe Hyperthyroidism. Thyroid. 2015;25:43---50, http://dx.doi.org/10.1089/thy.2014.0084.eng
dcterms.referencesTakata K, Amino N, Kubota S, Sasaki I, Nishihara E, Kudo T, et al. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves’ disease. Clin Endocrinol. 2010;72:845---50, http://dx.doi.org/10.1111/ j.1365-2265.2009.03745.x.eng
dcterms.referencesKinoshita H, Yasuda M, Furumoto Y, Watanabe N, Horiuchi T, Murayama M, et al. Severe Duodenal Hemorrhage Induced by Lugol’s Solution Administered for Thyroid Crisis Treatment. Intern Med. 2010;49:759---61, http://dx.doi.org/10.2169/ internalmedicine.49.2831.eng
dcterms.referencesMyung Park J, Seok Lee I, Young Kang J, Nyol Paik C, Kyung Cho Y, Woo Kim S, et al. Acute esophageal and gastric injury: Complication of Lugol’s solution. Scand J Gastroenterol. 2007;42:135---7, http://dx.doi.org/10.1080/00365520600825141.eng
dcterms.referencesHoogenberg K. Lithium as an Adjunct to Radioactive Iodine in Treatment-Resistant Graves Thyrotoxicosis. Ann Intern Med. 1998;129:670, http://dx.doi.org/10.7326/ 0003-4819-129-8-199810150-00025.eng
dcterms.referencesTagami T, Yambe Y, Tanaka T, Tanaka T, Ogo A, Yoshizumi H, et al. Short-Term Effects of -adrenergic Antagonists and Methimazole in New-Onset Thyrotoxicosis Caused by Graves’ Disease. Intern Med. 2012;51:2285---90, http://dx.doi.org/10.2169/ internalmedicine.51.7302.eng
dcterms.referencesChopra IJ, Williams DE, Orgiazzi J, Solomon DH. Opposite Effects of Dexamethasone on Serum Concentrations of 3, 3 ,5 -Triiodothyronine (Reverse T 3) and 3,3 ,5 -Triiodothyronine (T 3). J Clin Endocrinol Metab. 1975;41:911---20, http://dx.doi.org/10.1210/jcem-41-5-911.eng
dcterms.referencesWilliams DE, Chopra IJ, Orgiazzi J, Solomon DH. Acute Effects of Corticosteroids on Thyroid Activity in Graves’ Disease. J Clin Endocrinol Metab. 1975;41:354---61, http://dx.doi.org/10.1210/jcem-41-2-354.eng
dcterms.referencesSenda A, Endo A, Tachimori H, Fushimi K, Otomo Y. Early administration of glucocorticoid for thyroid storm: analysis of a national administrative database. Crit Care. 2020;24:470, http://dx.doi.org/10.1186/s13054-020-03188-8.eng
dcterms.referencesSolomon BL, Wartofsky L, Burman KD. Adjunctive cholestyramine therapy for thyrotoxicosis*. Clin Endocrinol. 1993;38:39---43, http://dx.doi.org/10.1111/j.1365-2265. 1993.tb00970.x.eng
dcterms.referencesKaykhaei MA, Shams M, Sadegholvad A, Dabbaghmanesh MH, Omrani GR. Low doses of cholestyramine in the treatment of hyperthyroidism. Endocrine. 2008;34:52---5, http://dx.doi.org/10.1007/s12020-008-9107-5.eng
dcterms.referencesMuller C, Perrin P, Faller B, Richter S, Chantrel F. Role of Plasma Exchange in the Thyroid Storm. Ther Apher Dial. 2011;15:522---31, http://dx.doi.org/10.1111/ j.1744-9987.2011.01003.x.eng
dcterms.referencesVyas AA, Vyas P, Fillipon NL, Vijayakrishnan R, Trivedi N. Successful Treatment of Thyroid Storm with Plasmapheresis in a Patient with Methimazole-Induced Agranulocytosis. Endocr Pract. 2010;16:673---6, http://dx.doi.org/10.4158/EP09265.CR.eng
dcterms.referencesSimsir IY, Ozdemir M, Duman S, Erdogan M, Donmez A, Ozgen AG. Therapeutic plasmapheresis in thyrotoxic patients. Endocrine. 2018;62:144---8, http://dx.doi.org/10.1007/ s12020-018-1661-x.eng
dcterms.referencesBuiles-Montano˜ CE, Rodriguez-Arrieta LA, Román-González A, Prieto-Saldarriaga C, Alvarez-Payares JC, Builes-Barrera CA, et al. Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi-center study. J Clin Apher. 2021;36:759---65, http://dx.doi.org/10.1002/jca.21927.eng
dcterms.referencesVinan-Vega M, Mantilla B, Jahan N, Peminda C, Nugent K, Lado-Abeal J, et al. Usefulness of plasmapheresis in patients with severe complicated thyrotoxicosis. Proc (Bayl Univ Med Cent). 2021;34:279---82, http://dx.doi.org/10.1080/ 08998280.2020.1852007.eng
dcterms.referencesOpalinska ´ M, Pantoflinski ´ J, Sokołowski G, Pach D, KosteckaMatyja M, Zabicka ˙ K, et al. Life-threatening amiodaroneinduced thyrotoxicosis --- Personalized approach to radical treatment. Heliyon. 2024;10:e34850, http://dx.doi.org/ 10.1016/j.heliyon.2024.e34850.eng
dcterms.referencesSeo GH, Kim TH, Chung JH. Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study. Ann Intern Med. 2018;168:405, http://dx.doi.org/10.7326/M17-1398.eng
dcterms.referencesScholz GH, Hagemann E, Arkenau C, Engelmann L, Lamesch P, Schreiter D, et al. Is There a Place for Thyroidectomy in Older Patients with Thyrotoxic Storm and Cardiorespiratory Failure? Thyroid. 2003;13:933---40, http://dx.doi.org/ 10.1089/105072503322511337.eng
dcterms.referencesSharma A, Stan MN. Thyrotoxicosis: Diagnosis and Management. Mayo Clin Proc. 2019;94:1048---64, http://dx.doi.org/10.1016/ j.mayocp.2018.10.011.eng
dcterms.referencesErbil Y, Ozluk Y, Giris¸ M, Salmashoglu A, Issever H, Barbaros U, et al. Effect of Lugol Solution on Thyroid Gland Blood Flow and Microvessel Density in the Patients with Graves’ Disease. J Clin Endocrinol Metab. 2007;92:2182---9, http://dx.doi.org/10.1210/jc.2007-0229.eng
dcterms.referencesAlexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27:315---89, http://dx.doi.org/10.1089/thy.2016.0457.eng
dcterms.referencesEmiliano AB, Governale L, Parks M, Cooper DS. Shifts in Propylthiouracil and Methimazole Prescribing Practices: Antithyroid Drug Use in the United States from 1991 to 2008. J Clin Endocrinol Metab. 2010;95:2227---33, http://dx.doi.org/ 10.1210/jc.2009-2752.eng
dcterms.referencesCarroll R, Matfin G. Review: Endocrine and metabolic emergencies: thyroid storm. Ther Advan Endocrinol Metab. 2010;1:139---45, http://dx.doi.org/10.1177/ 2042018810382481.eng
oaire.versioninfo:eu-repo/semantics/publishedVersion
sb.programaEspecialización en Medicina Internaspa

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos
Especialización

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca